A study to determine the safety and activity of Sorafenib in patients with locally recurrent or metastatic breast cancer � Trials Oncology Clinical Research Details


Clinical Research Detail

Title Of Study	A study to determine the safety and activity of Sorafenib in patients with locally recurrent or metastatic breast cancer

Disease Condition	Recurrent or metastatic breast cancer

Phase of Trial	Phase-2	Discipline	Oncology

Start date of Trial	3/10/2008	Closing Date of Trial	10/5/2013

If you are a doctor interested in clinical research then upload your profile. Click here

If you are a hospital interested in clinical research then upload your profile. Click here

If you are a patient interested to know more about this clinical trial mail us at: [email protected]

Ask Your Health Query

Consult with Experts

List of Oncology Clinical Trials

- Phase 3 clinical Study to Compare the Efficacy and Safety of drug product Panitumumab and Cetuximab in Subjects with Previously Treated Metastatic Colorectal Cancer.

- EGF102988 : This is a randomised, double-blind, placebo-controlled, multicentre, global Phase III trial comparing the efficacy of adjuvant oral lapatinib versus placebo in high-risk subjects with head and neck cancer following surgery. Lapatinib or placebo will be administered post-operatively in combination with chemoradiotherapy followed by maintenance with lapatinib or placebo for 1 year. The primary goal is to determine if lapatinib is effective at reducing the recurrence of the disease in these high-risk patients.

- A study to evaluate the Efficacy and Safety of AZD8931 in Combination with Anastrozole, compared to Anastrozole alone in Post-menopausal Women With Locally-advanced or Metastatic Breast Cancer.

Copyright © 2024 Ask4Healthcare.com